Myeloproliferative Philadelphia-Negative Syndromes

被引：0
|
作者：
Kiladjian, Jean-Jacques [1 ,2 ]
机构：
[1] Hop Avicenne, AP HP, Serv Hematol, 125 Rue Stalingrad, F-93000 Bobigny, France
[2] Univ Paris XIII, Villetaneuse, France
来源：
HEMATOLOGIE | 2007年 / 13卷
关键词：
D O I：
10.1684/hma.2007.0099
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：55 / 58
页数：4
相关论文
共 50 条
  • [21] How we manage Philadelphia-negative myeloproliferative neoplasms in pregnancy
    Robinson, Susan E.
    Harrison, Claire N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (04) : 625 - 634
  • [22] Evaluation of thrombin generation in classical Philadelphia-negative myeloproliferative neoplasms
    Olteanu, Ariela Ligia
    Mihaila, Romeo-Gabriel
    Mihalache, Manuela
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2016, 24 (03): : 279 - 289
  • [23] Characteristics and outcomes of young adults with Philadelphia-negative myeloproliferative neoplasms
    Barzilai, Merav
    Kirgner, Ilya
    Avivi, Irit
    Ellis, Martin
    Dally, Najib
    Rozovski, Uri
    Lavi, Noa
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (06) : 504 - 508
  • [24] Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms
    Barbara Mora
    Francesco Passamonti
    Current Hematologic Malignancy Reports, 2022, 17 : 127 - 139
  • [25] Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms
    Kaplan, Jason B.
    Stein, Brady L.
    McMahon, Brandon
    Giles, Francis J.
    Platanias, Leonidas C.
    EBIOMEDICINE, 2016, 3 : 17 - 25
  • [26] Proliferative characteristics of Philadelphia-negative myeloproliferative neoplasms - clinical implications
    Sefer, D.
    Bizic-Radulovic, S.
    Kraguljac-Kurtovic, N.
    Bogdanovic, A.
    Cokic, V.
    Miljic, P.
    Beleslin-Cokic, B.
    Knezevic, V.
    Mitrovic-Ajtic, O.
    Lekovic, D.
    Gotic, M.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 (01) : 21 - 31
  • [27] Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation
    Cacemiro, Maira da Costa
    Cominal, Jucara Gastaldi
    Tognon, Raquel
    Nunes, Natalia de Souza
    Simoes, Belinda Pinto
    de Figueiredo-Pontes, Lorena Lobo
    Bazzo Catto, Luiz Fernando
    Traina, Fabiola
    Souto, Elizabeth Xisto
    Zambuzi, Fabiana Albani
    Frantz, Fabiani Gai
    de Castro, Fabiola Attie
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2018, 40 (02) : 120 - 131
  • [28] Single chromosomal abnormalities in Philadelphia-negative chronic myeloproliferative disorders
    Panani, Anna D.
    IN VIVO, 2007, 21 (05): : 867 - 870
  • [29] Interferon Alfa in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms
    Hasselbalch, Hans Carl
    Kiladjian, Jean-Jacques
    Silver, Richard T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18) : E564 - E565
  • [30] Aspirin in Philadelphia-Negative Myeloproliferative Neoplasms: What Is the Optimal Dose ?
    Ajzenberg, Nadine
    Faille, Dorothee
    Huisse, Marie-Genevieve
    Anh Hong Cung
    Lamrani, Lamia
    Dumontier, Nicolas
    Jandrot-Perrus, Martine
    Cassinat, Bruno
    Chomienne, Christine
    Dosquet, Christine
    BLOOD, 2014, 124 (21)
12345